Clinical Trial Details

EORTC-1944-QLG-STBSG

Back to Clinical Trials Database

Long-term survivorship challenges of advanced/metastatic GIST patients responding to Imatinib treatment: An observational study

Study documentation

Trial Status Recruiting
Dates Date of activation: 24-Mar-2021
Data management at EORTC None
Design QoL Non Mod Dev.
Not randomized / N.A.
Treatment None
Study Staff Emma Lidington (Study Coordinator) , King's College London - Division of Cancer Studies, London
Melanie Beauvois (Clinical Operations Manager) , EORTC Headquarters, Brussels
Corneel Coens (Statistician) , EORTC Headquarters, Brussels
Ingrid Desar (Study Co-Coordinator) , Radboud University Medical Center Nijmegen, Nijmegen
Francesca Martinelli (QoL Specialist) , EORTC Headquarters, Brussels
Madeline Pe (QoL Specialist) , EORTC Headquarters, Brussels
Winette van der Graaf (Study Co-Coordinator) , The Netherlands Cancer Institute-Antoni Van Leeuwenhoekziekenhuis, Amsterdam
Type of cancer Soft Tissue and Bone Sarcoma
Participating groups EORTC Quality of Life Group
EORTC Soft Tissue and Bone Sarcoma Group
Protocol summary http://clinicaltrials.gov/study/
NCT number
Financial Support QOL Grant